Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.

MLA

Ishihara, Lianna, et al. “Screening for Lrrk2 G2019S and Clinical Comparison of Tunisian and North American Caucasian Parkinson’s Disease Families.” Movement Disorders, vol. 22, no. 1, Jan. 2007, pp. 55–61. EBSCOhost, https://doi.org/10.1002/mds.21180.

APA

Ishihara, L., Gibson, R. A., Warren, L., Amouri, R., Lyons, K., Wielinski, C., Hunter, C., Swartz, J. E., Elango, R., Akkari, P. A., Leppert, D., Surh, L., Reeves, K. H., Thomas, S., Ragone, L., Hattori, N., Pahwa, R., Jankovic, J., Nance, M., & Freeman, A. (2007). Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson’s disease families. Movement Disorders, 22(1), 55–61. https://doi.org/10.1002/mds.21180

Chicago

Ishihara, Lianna, Rachel A. Gibson, Liling Warren, Rim Amouri, Kelly Lyons, Catherine Wielinski, Christine Hunter, et al. 2007. “Screening for Lrrk2 G2019S and Clinical Comparison of Tunisian and North American Caucasian Parkinson’s Disease Families.” Movement Disorders 22 (1): 55–61. doi:10.1002/mds.21180.